Quality of Care in Relationship to Aborted Cancer Surgery

Developing Patient-centered Interventions to Improve the Quality of Care in Relationship to Aborted Cancer Surgery

Surgery is often a central curative treatment for gastrointestinal tumors. Surgical treatment of diagnosed cancer tumors is decided after a comprehensive assessment of the patient's physical status, radiological assessments and after careful evaluation at the multidisciplinary conference. Despite the careful preoperative assessment of patients for curative surgery, the planned operation may unexpectedly need to be canceled. Of the patients who were planned for curative resection for pancreatic cancer in 2021 in Sweden, 90% received the intended surgery, and 10% of planned surgery was canceled. The reason for this was disseminated cancer or locally advanced disease in which radical resection is considered impossible to carry out. A systematic review of knowledge reveals a significant lack of evidence regarding patient-centered research and aborted cancer surgery.

The studies in the project have different study designs and methods, and include focus group interviews with staff, translation and validation of a questionnaire to measure care needs, estimation of supportive care needs and patient experiences.

An improved understanding and knowledge of patients' preferences and needs is needed to design interventions that can improve health-related quality of life. This project is dedicated to studying patients undergoing aborted cancer surgery, with the aim of improving the quality of care and meeting patients' care needs.

Study Overview

• Status: Recruiting
• Conditions: Cancer; Gastrointestinal Cancer
• Intervention / Treatment: Other: validation

Detailed Description

The overall objective of this research project is to:

• describe the patients experiences and assess supportive care needs following aborted cancer gastrointestinal surgery
• increase knowledge of the healthcare professionals' experiences of aborted cancer surgery from a multi-professional and continuum of cancer care perspective
• increase our clinical knowledge of patient preferences and healthcare professionals' perspective to develop tailored patient-centered interventions with the goal to improve quality of cancer care

• Study Type: Observational
• Enrollment (Estimated): 350

Contacts and Locations

• Study Contact: Name: Jenny Drott, PhD; Phone Number: +46 732701839; Email: Jenny.Drott@liu.se
• Study Contact Backup: Name: Per Sandström, Prof; Phone Number: +46 7034058581; Email: per.sandstrom@liu.se

Study Locations

• Sweden
  • Linköping, Sweden, 581 83
    • Recruiting
    • Jenny Drott
    • Contact: Jenny Drott; Phone Number: +46709544489; Email: Jenny.Drott@liu.se
  • Linköping, Sweden, 58185
    • Recruiting
    • Department of Surgery
    • Contact: Per Sandström; Phone Number: +467034058581; Email: per.sandstrom@liu.se

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Cancer patients with different gastrointestinal cancer diagnosis

Description

Inclusion Criteria:

• >18 years
• cancer patients with different gastrointestinal cancer diagnosis

Exclusion Criteria:

- not able to answer the questionnarie SCNS-SF34 in Swedish.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Translation and validation design; To translate the English version of The Supportive Care Needs Survey-short form (SCNS-SF34) questionnaire into Swedish and to test the reliability and validity. Design: Translation and validation design A multicenter national validation study, in three university hospital in Sweden. Consecutive sampling procedure during a one-year period (2023), to evaluate internal consistency and test-retest reliability of the SCNS-SF34 in Swedish. Number is calculated to be 300 patients, and test-rest (reliability) in 50 patients. Inclusion criteria = >18 years, cancer patients with different gastrointestinal cancer diagnosis. Exclusion criteria= not able to answer a questionnaire in Swedish. Demographical and clinical data will be collected using a case report form. The survey will be distributed to patients via a web-based questionnaire or paper and pen questionnaire procedure.

Other: validation; Translation and validation design

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
supportive care needs, questonnarie	psychometric properties in the swedish version of the questionnarie SCNS-SF34	March 2023 - March 2024
Rate of supportive care needs in cancer	assessment of supportive care needs via the questionnarie SCNS-SF34 (in Swedish)	March 2023 - March 2024

Collaborators and Investigators

• Sponsor: Linkoeping University
• Investigators: Principal Investigator: Jenny Drott, Kirurgiska kliniken, Region Östergötland

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2023
• Primary Completion (Estimated): December 31, 2028
• Study Completion (Estimated): December 31, 2028

Study Registration Dates

• First Submitted: March 28, 2023
• First Submitted That Met QC Criteria: April 10, 2023
• First Posted (Actual): April 11, 2023

Study Record Updates

• Last Update Posted (Actual): June 8, 2025
• Last Update Submitted That Met QC Criteria: June 4, 2025
• Last Verified: June 1, 2025

More Information

Terms related to this study

• Keywords: patient-centered care; patient preferences; cancer nursing,
• Additional Relevant MeSH Terms: Neoplasms by Site; Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms
• Other Study ID Numbers: ACS

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No